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Abstract
Small heat-shock proteins (sHsps) are molecular chaperones that play an important protective role
against cellular protein misfolding by interacting with partially unfolded proteins on their off-folding
pathway, preventing their aggregation. Polyglutamine (polyQ) repeat expansion leads to the formation of
fibrillar protein aggregates and neuronal cell death in nine diseases, including Huntington disease and the
spinocerebellar ataxias (SCAs). There is evidence that sHsps have a role in suppression of polyQ-induced
neurodegeneration; for example, the sHsp alphaB-crystallin (αB-c) has been identified as a suppressor of
SCA3 toxicity in a Drosophila model. However, the molecular mechanism for this suppression is unknown.
In this study we tested the ability of αB-c to suppress the aggregation of a polyQ protein. We found that
αB-c does not inhibit the formation of SDS-insoluble polyQ fibrils. We further tested the effect of αB-c on
the aggregation of ataxin-3, a polyQ protein that aggregates via a two-stage aggregation mechanism. The
first stage involves association of the N-terminal Josephin domain followed by polyQ-mediated
interactions and the formation of SDS-resistant mature fibrils. Our data show that αB-c potently inhibits
the first stage of ataxin-3 aggregation; however, the second polyQ-dependent stage can still proceed. By
using NMR spectroscopy, we have determined that αB-c interacts with an extensive region on the surface
of the Josephin domain. These data provide an example of a domain/region flanking an amyloidogenic
sequence that has a critical role in modulating aggregation of a polypeptide and plays a role in the
interaction with molecular chaperones to prevent this aggregation.
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Small heat-shock proteins (sHsps) are molecular chaperones that
play an important protective role against cellular protein misfolding
by interacting with partially unfolded proteins on their off-folding
pathway, preventing their aggregation. Polyglutamine (polyQ)
repeat expansion leads to the formation of fibrillar protein aggregates and neuronal cell death in nine diseases, including Huntington
disease and the spinocerebellar ataxias (SCAs). There is evidence
that sHsps have a role in suppression of polyQ-induced neurodegeneration; for example, the sHsp alphaB-crystallin (αB-c) has been
identified as a suppressor of SCA3 toxicity in a Drosophila model.
However, the molecular mechanism for this suppression is unknown. In this study we tested the ability of αB-c to suppress the
aggregation of a polyQ protein. We found that αB-c does not inhibit
the formation of SDS-insoluble polyQ fibrils. We further tested the
effect of αB-c on the aggregation of ataxin-3, a polyQ protein that
aggregates via a two-stage aggregation mechanism. The first stage
involves association of the N-terminal Josephin domain followed by
polyQ-mediated interactions and the formation of SDS-resistant
mature fibrils. Our data show that αB-c potently inhibits the first
stage of ataxin-3 aggregation; however, the second polyQ-dependent stage can still proceed. By using NMR spectroscopy, we have
determined that αB-c interacts with an extensive region on the
surface of the Josephin domain. These data provide an example
of a domain/region flanking an amyloidogenic sequence that has
a critical role in modulating aggregation of a polypeptide and plays
a role in the interaction with molecular chaperones to prevent this
aggregation.
fibrillogenesis ∣ α-crystallin

S

mall heat-shock proteins (sHsps) are important in the maintenance of cellular homeostasis. sHsps are induced under
stress conditions and interact with partially unfolded proteins
on their off-folding pathways, thereby providing a protective
mechanism against protein misfolding and aggregation (1). They
are present in many species, and 10 have been identified in the
human proteome (see reviews in refs. 1 and 2). Alpha-crystallin
(α-crystallin) is the most well characterized sHsp. The two isoforms
of α-crystallin, αA-crystallin (αA-c) and αB-crystallin (αB-c), are a
large component of the human eye lens, and αB-c is expressed in
many other cell types including neurons (3, 4). Monomeric αB-c is
approximately 20 kDa in mass, and under native conditions it
forms a heterogeneous array of multimeric complexes ranging
from 160 to 1,000 kDa in mass (2). The activity of αB-c is thought
to involve hydrophobic interactions between αB-c and the partially
folded protein. Under stress conditions, such as elevated temperature, the activity of αB-c is enhanced because of a conformational
change within the multimeric complex (5, 6). Cellular stress is induced in several neurodegenerative diseases, such as Alzheimer’s
disease (7), prion diseases (8), Parkinson disease (4), and Huntington disease (HD) (4), and there is evidence of increased αB-c
activity (4). In addition, αB-c reduces neurotoxicity in a number
of disease models (9, 10). In vitro the interaction between

10424–10429 ∣ PNAS ∣ June 8, 2010 ∣ vol. 107 ∣ no. 23

αB-c and a number of aggregating proteins has been characterized.
Most substrates aggregate through a nucleation-dependent kinetic
mechanism; however, the mode of interaction with αB-c appears
to be dependent upon the specific target protein and the type of
aggregation—i.e., amorphous or fibrillar (11–13). Complex stability is influenced by properties of the target protein, for example,
the fibril-forming proteins apolipoprotein-CII (11) and amyloid-β
(14) transiently interact with αB-c whereas α-synuclein (6) and
κ-casein (15) form stable noncovalent complexes. Determining
the mechanism by which αB-c interacts with specific aggregation-prone substrates is therefore important and may provide
insight into the misfolding pathways leading to toxicity.
Polyglutamine (polyQ) expansion leads to the formation of
fibrillar protein aggregates and neuronal cell death in nine diseases, including HD and the spinocerebellar ataxias (SCAs) 1,
2, 3, 6, 7, and 17. PolyQ peptides and proteins form fibrillar aggregates by a nucleation-dependent mechanism that is initiated
by a monomeric nucleus (16–18). Recent evidence suggests that
polyQ protein misfolding involves not only the polyQ tract but
other aggregation-prone regions within the polyQ proteins
(19–21). There is experimental evidence that the proteins ataxin-3 (in SCA3), ataxin-1 (in SCA1), and huntingtin (in HD) form
fibrillar aggregates by a multidomain misfolding mechanism in
which non-polyQ regions of the protein self-associate before
the polyQ tract (19, 20, 22). Our laboratory has previously shown
that ataxin-3 has a minimal two-stage aggregation mechanism
(19). The first stage involves aggregation of the globular N-terminal Josephin domain that precedes the self-association of
expanded polyQ segments (19).
sHsp overexpression decreases neuronal toxicity in HD by
nonchaperone mechanisms, including suppression of reactive
oxygen species (23) and stimulation of autophagy (24). In disease
models overexpression of αB-c modulates toxicity in a contextdependent manner. αB-c did not alter the HD phenotype in a
Drosophila model (25); however, it suppressed SCA3 toxicity
in a Drosophila model (9). Enhanced suppression was observed
when αB-c was coexpressed with full-length ataxin-3 in comparison with a C-terminal fragment not containing the Josephin
domain (9). These data suggest that non-polyQ protein regions
influence sHsp chaperone activity.
In this study we tested the chaperone ability of αB-c for a
polyQ protein (SpAcQ52) that forms fibrillar aggregates by a
mechanism involving only the polyQ region. We found that
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Results
αB-c Does Not Inhibit PolyQ-Mediated Aggregation. We first tested

whether αB-c can prevent polyQ tract-mediated aggregation. We
coincubated αB-c with a polyQ protein (SpAcQ52), which forms
SDS-insoluble aggregates by a mechanism involving only the
polyQ tract (26). The rate at which SpAcQ52 forms ThT-reactive
aggregates does not change when incubated with increasing
concentrations of αB-c (Fig. 1A). It has been previously shown
that molecular chaperones can redirect the aggregation pathway
of a protein from amyloid to amorphous aggregation (27, 28).
Amorphous aggregates can be differentiated from amyloid by
their sensitivity to SDS and appearance when visualized by transmission electron microscopy (TEM). So we tested whether
SpAcQ52 incubated with αB-c forms SDS-insoluble aggregates
by using a membrane filter-trap assay (29). These data demonstrate that the aggregates formed in the presence or absence
of αB-c are insoluble in SDS (Fig. 1B). In addition, TEM analysis
of the aggregates indicated that αB-c does not affect their fibrillar
morphology. Fibrils ranging from 15 to 8 nm in width and 300 to
400 nm in length were observed in both the presence and absence
of αB-c (Fig. 1C). Together, these data demonstrate that αB-c
does not inhibit or modify the fibrillar aggregation of SpAcQ52.

Fig. 1. The effect of αB-c on poly(Q) aggregation. (A) SpAcQ52 aggregation
in the presence of increasing concentrations of αB-c monitored by ThT
fluorescence. (B) Analysis of the SDS solubility of endpoint aggregates
(100 h) in the presence and absence of αB-c. (C and D) TEM analysis of
SpAcQ52 aggregates in the absence (C) and presence of αB-c. Ratios of
SpAcQ52:αB-c are given on a molar basis.
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αB-c Inhibits the Josephin-Dependent Stage of the Two-Stage Ataxin-3
Aggregation Pathway. We have previously reported that full-length

ataxin-3 forms aggregates by a two-stage mechanism (18). The
aggregates formed in both stages are ThT-reactive, and in the absence of glycerol the two stages are characterized by a biphasic
time course (Fig. 2A). The first stage is dominated by interactions
of the N-terminal Josephin domain, which is an independently
aggregation-prone domain (30). Aggregates formed during the
first stage appear as short curvilinear structures and can be solubilized by SDS (19). These aggregates are stabilized in the second
stage by interactions of the polyQ regions. Stage-two aggregates
can be distinguished from stage-one aggregates because they are
SDS-insoluble and morphologically appear as larger fibrillar
structures. We determined the effect of αB-c on the two-stage
aggregation pathway of at3(Q64). αB-c significantly slows the formation of ThT-reactive at3(Q64) aggregates in a concentrationdependent manner (Fig. 2A and Table 1).
The Josephin domain forms short aggregates with a ribbon-like
morphology (30); however, the aggregation kinetics have not
been described. Isolated Josephin forms ThT-reactive aggregates
at a much slower rate than at3(Q64) (Fig. 2B and Table 1). The
half-life of the first ThT-reactive phase of at3(Q64) aggregation
represents the formation of Josephin-dependent fibrils (19). The
half-life shifts from approximately 9 h in the full-length protein to
around 60 h for the isolated Josephin domain (Table 1). These
data indicate that the C-terminal polyQ tail in the context of
the full-length protein accelerates Josephin domain aggregation.
αB-c has potent inhibitory activity on the aggregation of Josephin (Fig. 2B and Table 1), compared to the full-length at3(Q64)
variant. Thus, an equimolar concentration of αB-c completely
suppresses Josephin aggregation, but at3(Q64) still forms some
ThT-reactive aggregates, even when αB-c is present in a 2∶1
molar excess. The reaction time course is too long to determine
if the biphasic ThT pattern is altered at stoichiometric concentrations of αB-c. The potent inhibitory effect of αB-c on Josephin
aggregation, combined with the data in Fig. 1 showing that αB-c
does not inhibit polyQ-dependent aggregation, suggests that the
slow ThT phase in the presence of high αB-c concentrations is
dominated by polyQ intermolecular interactions.
We analyzed the Josephin and at3(Q64) fibrils by TEM
(Fig. 3A). Josephin forms short curvilinear fibrils, 5–10 nm in
width and 10–100 nm long, when incubated alone. However,

Fig. 2. The effect of αB-c on at3 aggregation. (A) At3(Q64) and (B) Josephin
aggregation in the presence of increasing concentrations of αB-c monitored
by ThT-fluorescence. Ratios of at3 variant:αB-c are given on a molar basis.
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αB-c does not inhibit fibrillogenesis in this system. We then tested
the effect of αB-c on the aggregation of ataxin-3 harboring a
pathological length polyQ tract [at3(Q64)] and a truncated
variant comprising only the Josephin domain. Our data show that
αB-c potently inhibits the initial Josephin-dependent stage of
ataxin-3 aggregation. By using NMR spectroscopy, we determined that αB-c interacts with specific regions of Josephin. These
data provide an example and characterization of a domain/region
flanking an amyloidogenic sequence that has a critical role in modulation of aggregation by interacting with molecular chaperones.

Table 1. Half-lives (in hours) of Ataxin-3(Q64) aggregation followed
by ThT and SDS insolubility in the presence and absence of αB-c
SDS
insolubility

ThT
Stage 1
Ataxin-3(Q64)
Ataxin-3(Q64) 10∶1 αB-c
Ataxin-3(Q64) 1∶1 αB-c
Josephin
Josephin 10∶1 αB-c
Josephin 1∶1 αB-c

9.3 ±
19.7 ±
*
59.1 ±
174 ±
‡

Stage 2

0.2
0.6

31.7 ± 0.9
49 ± 4
*

25.5 ± 1.1
45.1 ± 1.3
*

3
0.3

†

†

†

†

†

†

*Aggregation incomplete after 300 h; therefore, data could not be fitted.
†
Josephin does not undergo stage 2 of the ataxin-3 aggregation pathway and
therefore does not form SDS-insoluble fibrils.
‡
An equimolar amount of αB-c completely inhibited Josephin aggregation
over 300 h.

no fibrils were observed in samples incubated with equimolar
concentrations of αB-c. Small, spherical aggregates characteristic
of oligomeric αB-c are observed (Fig. 3A). After 7 h of incubation, curvilinear worm-like aggregates, 5–15 nm in width, consistent with the previously described morphology of stage-one
aggregates (19), were observed in samples of at3(Q64) incubated
alone. In the presence of αB-c, there were very few small aggregates present after 7 h. After 24 h, at3(Q64) was beginning to
form larger fibrillar structures, ranging from 200 to 300 nm in
length and 12 to 30 nm in width. These are consistent with the
morphology of stage-two/endpoint fibrils. There were very few
stage-two fibrils present in the samples incubated with αB-c.
At3(Q64) Forms SDS-Insoluble Fibrils at a Rate Modulated by Increasing αB-c Concentrations. We tested the effect of αB-c on the forma-

tion of SDS-resistant at3(Q64) fibrils by using the filter-trap assay.
Analysis of the membranes by densitometry showed that αB-c
retards the formation of SDS-insoluble fibrils, as demonstrated

Fig. 3. The effect of αB-c on the formation of at3(Q64) SDS-insoluble fibrils.
(A) TEM analysis of Josephin and ataxin-3 fibrils. (B) The poly(Q)-dependent
stage of At3(Q64) aggregation was monitored by detection of SDS-insoluble
fibrils using the membrane filter-trap assay. Membranes were analyzed by
densitometry and data normalized.
10426 ∣
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by a twofold increase in half-life for at3(Q64) aggregation occurring in the presence of substoichiometric concentrations of αB-c
[at3(Q64) 10∶1 αB-c] (Fig. 3B and Table 1). The inhibitory effect
of αB-c is more pronounced at stoichiometric concentrations
where SDS-insoluble fibrils were still formed but at much lower
amounts relative to at3(Q64) incubated alone. The equimolar data
could not be fit to the classic nucleation-dependent model because
aggregation is incomplete over the 300-h time scale.
The Presence of αB-c Retains Ataxin-3 in a Monomeric Conformation.

αB-c exists as a dynamic oligomeric complex (2). Depending
on the target protein, it can irreversibly or transiently bind to
target proteins, thereby inhibiting aggregation. To determine
the stability of the αB-c:at3 association we performed size-exclusion chromatography (SEC) of Josephin and at3(Q64) incubated
with equimolar concentrations of αB-c (Fig. 4).
Monomeric Josephin eluted from a Superose 6 column at
approximately 18.9 mL. After 24-h incubation, Josephin formed
insoluble aggregates that were removed by centrifugation prior to
injection onto the column; therefore, the monomeric protein
peak eluting at 18.9 mL was diminished (Fig. 4, Top Left). αBc displayed a broad peak centered around 14 mL, consistent with
αB-c being present as a polydisperse oligomer. In the presence of
αB-c, most of the Josephin is retained in a monomeric conformation at 49 h, with some recruited into the αB-c complex, observed
by a distinct shift and broadening of the αB-c peak (Fig. 4, Top
Right). We performed SDS-PAGE to examine the composition
of the peaks eluting at various times in the SEC experiments
(Fig. S1A). A small amount of Josephin coelutes with the multimeric αB-c complex after a 48-h incubation period, and this is
consistent with the shift and broadening of the peak corresponding to multimeric αB-c (Fig. 4).
At3(Q64) eluted as a single peak with a retention volume of
approximately 17.8 mL. After 8 h, most of the at3(Q64) had
aggregated, indicated by the presence of a large peak in the void
volume (approximately 8 mL) of the Superose 6 column (Fig. 4,
Bottom Left). After 8 h in the presence of αB-c, most of the at3
(Q64) is retained in a monomeric conformation, with little
change in the elution profile after this time (Fig. 4, Bottom Right).
No at3(Q64) coeluted with the multimeric αB-c (Fig. S1B),
consistent with the observation that the αB-c peak did not shift
in the experiments with at3(Q64) (Fig. 4). The SEC data suggest
that αB-c does not form a stable complex with at3(Q64)/Josephin
maintaining the proteins in a monomeric conformation.
Addition of αB-c Affects Josephin/at3(Q64) Fibril Propagation. The observation that αB-c retains Josephin and at3(Q64) in a monomeric
conformation suggests that αB-c inhibits the conformational
changes involved in nucleation of aggregation. αB-c has also been
shown to inhibit fibril propagation in a number of systems
(6, 11, 14, 27). We tested the effect of αB-c on Josephin and at3
(Q64) fibril propagation by adding αB-c at various intervals after
the commencement of aggregation.
When αB-c was added to isolated Josephin at 48 and 96 h,
there was no further increase in ThT intensity, suggesting that
αB-c prevents the further propagation of Josephin fibrils
(Fig. S2A). Similar behavior is observed when αB-c is added at
time points along the aggregation pathway of α-synuclein (6).
When αB-c was added to the at3(Q64) reactions at various
intervals, there was a flattening of the curve for a period of time
and then a second slower aggregation phase (Fig. S2B). Because
of the absence of this phase in the isolated Josephin reactions, we
predict that the second phase is because of polyQ-dependent
aggregation. Interestingly, the length of the flattened period
was longer when αB-c was added at earlier time points in comparison to later time points, supporting the hypothesis that the
rate at which poly(Q) interactions occurs is accelerated by the
initial formation of stage-one Josephin-dependent fibrils.
Robertson et al.

αB-c Interacts with an Extensive Region of Josephin. The ability of
αB-c to inhibit ataxin-3 aggregation appears to be derived from inhibition of the Josephin-dependent stage (stage one) of the multidomain aggregation pathway. We used NMR spectroscopy to probe
the molecular details of the Josephin:αB-c interaction surface.
The NMR data show that αB-c interacts with an extensive
region of Josephin (Fig. 5). A number of backbone amide crosspeaks in the 15 N-HSQC (heteronuclear single quantum coherence) spectrum of Josephin were significantly broadened upon
titration of αB-c up to a fivefold stoichiometric excess (Fig. S3).
The broadening is consistent with exchange between the free

Fig. 5. αB-c interacts with specific regions of Josephin. (A and B) The residues
perturbed upon addition of αB-c were mapped onto the Josephin domain
(Protein Data Bank ID code 1YZB). Residues in intermediate exchange in
the presence of αB-c (Red), residues shielded from broadening by Gd
(DTPA-BMA) in the presence of αB-c (Yellow), and orange shows the overlapping residues. A and B show opposing faces of the Josephin structure.
(C and D) The electrostatic surface of Josephin. Blue represents positive
charge and red indicates negatively charged regions. C and D show opposing
faces of the Josephin structure.

Robertson et al.

and αB-c bound states of Josephin. Exchange broadening occurs
when the time scale of the interaction is commensurate with the
difference in NMR frequencies between the bound and free states,
which is consistent with the transient interaction mechanism
observed by SEC (Fig. 4). The Josephin residues perturbed to
the largest degree were Q16, L19, N21, E26, S29, S35, I36, I77,
W87, Q100, C114, V123, G127, F131, S135, L137, T138, L148,
L155,Q156, E158, I162, Q176, and R182. These residues are confined to the globular subdomain of Josephin and include the active
site residue C114.
Because chemical shift perturbations can arise through
indirect mechanisms (rather than a direct interaction between
αB-c and Josephin), we used the paramagnetic relaxation agent
Gd-diethylenetriamine pentaacetic acid-bismethylamide [Gd
(DTPA-BMA)] to independently confirm the interaction surface
(31, 32). The presence of Gd(DTPA-BMA) in solution causes
paramagnetic relaxation enhancement, broadening the protein
resonances. By performing these 15 N-HSQC experiments in the
presence and absence of αB-c, we could determine the αB-c interaction surface of Josephin, because the regions that interact with
αB-c were partially shielded from paramagnetic relaxation
(Fig. S4). Josephin residues that had >20% stronger signals in
the presence of Gd(DTPA-BMA) and a twofold excess of αB-c
were S3, G11, L13, Q24, F28, A49, E50, G51, G52, T54, E56,
D57, R59, T60, F61, S66, D71, G73, F75, S76, E90, N115,
K128, N132, G139, L142, F151, G159, D168, E173, L178,
M180, and I181. The identity of these residues correlates well with
those broadened in the αB-c-bound state of Josephin (see above,
Fig. 5). When mapped to the Josephin structure all of the residues
that appeared to be most shielded from the paramagnetic probe by
the presence of αB-c were found to be surface-exposed, validating
these regions as the αB-c binding interface.

Fig. 6. A schematic model describing the effect of αB-c on at3 aggregation.
Multimeric αB-c (a sHsp) transiently binds to at3 molecules in which Josephin
is in an aggregation-prone conformation (Jagg ). The J:sHsp complex is
unstable, and monomeric Josephin is released from the sHsp.
PNAS ∣
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Fig. 4. Ataxin-3 aggregation in the presence and absence of αB-c monitored by SEC. Samples of Josephin and At3(Q64) incubated in the presence and absence
of αB-c were removed at indicated time points and analyzed by SEC using a Superose 6 column. In the samples containing αB-c, equimolar amounts of substrate:
αB-c were used.

Discussion
sHsps Do Not Inhibit PolyQ Aggregation. sHsps have a critical role in

cellular homeostasis and can provide a barrier to the aggregation
of partially unfolded proteins that are central to many neurodegenerative diseases. We investigated the effect of αB-c on the aggregation of a polyQ-containing model protein, finding that αB-c
does not affect the formation of SDS-resistant polyQ fibrils when
fibril formation is entirely polyQ-dependent (Fig. 1). Typically,
sHsps (along with many other molecular chaperones) interact with
exposed hydrophobic patches on target proteins. Glutamine is a
hydrophilic amino acid; therefore, the surface hydrophobicity of
polyQ would not increase during early aggregation stages. In addition, the polyQ region is thought to be in a condensed disordered
state in the native ensemble (33, 34), therefore decreasing the
accessibility of the side chains to sHsp interactions (35). In a manner akin to our findings with sHsps, molecular chaperones from
other classes, e.g., Hsp70 and the chaperonin TRiC, which recognize surface hydrophobic patches of amyloidogenic intermediates,
only weakly associate with polyQ proteins (28, 36). Therefore, the
physiochemical properties of the polyQ tract may lead to its
evasion by some chaperone protective mechanisms.
αB-c Inhibits the Josephin-Dependent Stage of Ataxin-3 Aggregation.

Pathological polyQ tracts are located within specific host proteins,
and properties of the host protein are known to modulate aggregation and cellular toxicity (37, 38). Although molecular chaperones
do not alter the misfolding of pure polyQ, genetic screens in Drosophila and Caenorhabditis elegans have identified several chaperones that modulate toxicity induced by ataxin-3, ataxin-1, and Htt
exon 1, proteins that contain well-structured domain(s) coupled to
a polyQ repeat (9, 39). As a result, we hypothesize that non-polyQ
aggregation mechanisms play a role in pathogenesis. A previous
study from our group has described a two-stage aggregation mechanism for pathological variants of ataxin-3 (19). Our data show
that αB-c inhibits nucleation of the Josephin-dependent stage of
ataxin-3 aggregation, subsequently having an indirect effect on
the rate of poly(Q) intermolecular interactions. The chaperonin
TRiC was recently shown to have a similar effect on the aggregation
of Htt exon 1; TRiC suppresses aggregation by binding to the
N-terminal domain adjacent to the polyQ tract (40).
αB-c had a more potent inhibitory effect on the aggregation of
Josephin alone compared with at3(Q64). The Josephin aggregation stage is enhanced when this domain is part of at3(Q64),
suggesting that the presence of the polyQ-containing C-terminal
tail increases the rate of Josephin aggregation. The presence of
the C-terminal polyQ tail leads to a slight decrease in the thermodynamic stability of Josephin (41), and we speculate that the
tail alters the dynamic properties of the core domain enhancing
the rate of conformational rearrangements on the aggregation
pathway. The observation that αB-c has a greater inhibitory effect
on the aggregation of isolated Josephin can be rationalized by a
previous study demonstrating that larger target proteins require
more αB-c (on a molar basis) for complete suppression of aggregation (42). The altered potency is also consistent with data showing that αB-c has a preference for target proteins that aggregate
more slowly (43).
For the full-length protein, the interaction of αB-c with
Josephin significantly slows the subsequent poly(Q)-dependent
aggregation (Fig. 1 and Table 1). These data suggest that Josephin
self-interactions lower the kinetic barrier to poly(Q)-dependent
aggregation. The multidomain aggregation mechanisms described
for ataxin-3 and Htt exon 1 suggest that a pool of small stage-one
species can enhance the rate of polyQ-dependent aggregation by
increasing the local polyQ concentration (19, 20). This suggestion
is consistent with our data (Fig. S2B), which demonstrated
that the formation of small Josephin fibrils is necessary for efficient
formation of poly(Q)-dependent SDS-insoluble fibrils.
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The significant effect of αB-c on ataxin-3 aggregation is
consistent with a Drosophila model in which overexpression of
αB-c decreased SCA3-induced toxicity (9), suggesting that inhibition of aggregation by chaperones is relevant in vivo. Another
Drosophila study demonstrated that chaperone-induced retention
of ataxin-3 in a monomeric conformation suppresses toxicity (44).
Conversely, αB-c overexpression had no effect on the HD
phenotype (25). Htt exon 1 has been proposed to have a similar
two-stage aggregation mechanism compared to ataxin-3 (20). The
alternative effects of αB-c in the ataxin-3 and Htt systems demonstrate how specific differences in multidomain misfolding pathways could lead to variable cellular responses.
αB-c Transiently Interacts with Monomeric Josephin. The aggregation
data clearly show that αB-c suppresses aggregation by associating
with species on the Josephin aggregation pathway. Our SEC and
NMR data show that inhibition mechanistically occurs by transient
association of αB-c with a defined region on the Josephin surface
that is partially coincident with the ubiquitin and HHR23B interacting surfaces (45–47). Interestingly, the perturbed residues are
not all hydrophobic in character, and it is possible that some surface
polar residues appear perturbed in our NMR studies because their
amide groups are neighboring interacting hydrophobic groups.
Whereas hydrophobic interactions are clearly important for chaperone action, it is also being increasingly recognized that substrate
specificity is not purely driven by hydrophobic contacts (48–50).
The SEC data show that the proteins are retained in a monomeric conformation in the presence of αB-c (Fig. 4). These data
suggest that the rate at which αB-c interacts with Josephin is more
rapid than the rate of misfolding. The NMR data indicate that
this is a low affinity interaction; therefore, during this interaction,
most of the Josephin is in a monomeric uncomplexed state. These
data are consistent with a mechanism whereby αB-c binds and
sequesters the free pool of monomeric proteins, thereby preventing fibril growth (Fig. 6).
The interaction between αB-c and monomeric Josephin,
encompassing a large region of the target protein, is also observed, in the interaction of αB-c with the fibril-forming proteins
α-synuclein (27) and κ-casein (6).

Conclusions
Our data demonstrate that inhibition of a non-polyQ aggregation
stage by a chaperone can significantly impede protein aggregation involved in polyQ diseases. These data support the two-stage
model as a plausible scheme for ataxin-3 aggregation in vitro.
Therapeutic up-regulation of chaperone activity may be beneficial in SCA3 and other polyQ diseases that have a multidomain
aggregation mechanism.
Experimental Procedures
Preparation of Proteins. SpAcQ52 and the ataxin-3 variants used in
this study were expressed and purified as previously described
(26, 51). αB-c was expressed and purified as described in ref. 52.
Protein Aggregation Assays. Aggregation assays were performed for
SpAcQ52 and ataxin-3 variants at a protein concentration of
20 μM in Tris-buffered saline (TBS) (100 mM Tris, 80 mM NaCl,
pH 7.4) containing 2 mM PMSF, 5 mM EDTA, and 15 mM
ß-mercaptoethanol. Variable concentrations of αB-c were added
to the samples, ranging from 2 to 40 μM. Samples were incubated
at 37 °C.
ThT Measurements, Membrane Filter-Trap Assay, and TEM. ThT measurements, the membrane filter-trap assay, and TEM analysis
were performed as described in refs. 19 and 26.
SEC. SEC of at3(Q64) and Josephin in the presence and absence

of equimolar concentrations of αB-c was performed on an AktaRobertson et al.

FPLC equipped with a Superose 6 10/300 GL column (Pharmacia). Prior to injection onto the column, samples were centrifuged
for 5 min at 13,000 rpm to remove insoluble aggregated material.
The absorbance at 214 nm was measured as proteins were eluted
in TBS buffer at a constant flow rate of 0.5 mL∕ min.

NMR Spectroscopy. NMR methods are described in SI Text.
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